Trials / Completed
CompletedNCT04899674
A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood
An Open-label, Two-period Fixed Sequence Trial to Evaluate the Effect of Multiple Doses of BI 1358894 on the Pharmacokinetics of Bupropion in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The main objective of this trial is to investigate the relative bioavailability of a single dose of bupropion when given alone (Reference) compared with co-administration (Test) with BI 1358894 in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Elontril | Tablet |
| DRUG | BI 1358894 | Film coated tablet |
Timeline
- Start date
- 2021-06-30
- Primary completion
- 2021-09-02
- Completion
- 2021-09-02
- First posted
- 2021-05-24
- Last updated
- 2025-02-24
- Results posted
- 2025-02-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT04899674. Inclusion in this directory is not an endorsement.